Skip to main content
SpringerLink
Log in

Chronische Inflammation als Promotor- und Behandlungstarget bei benigner Prostatahyperplasie (BPH) und beim Prostatakarzinom

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Kramer G, Mitteregger D, Marberger M et al. (2006) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51: 1202–1216

    Article  PubMed  Google Scholar 

  2. Kramer G, Marberger M (2006) Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 16: 25–29

    PubMed  Google Scholar 

  3. Klyushnenkova EN, Ponniah S, Rodriguez A et al. (2004) CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis. J Immunother 27: 136–146

    Article  PubMed  CAS  Google Scholar 

  4. Klyushnenkova EN, Link J, Oberle WT et al. (2005) Identification of HLA-DRB1*1501-restricted T-cell epitopes from prostate-specific antigen. Clin Cancer Res 11: 2853–2861

    Article  PubMed  CAS  Google Scholar 

  5. Steiner GE, Kramer G, Madersbacher S et al. (1999) Search for autoactive bodies in the sera of BPH patients. J Urol 4:228

    Article  Google Scholar 

  6. Kramer G, Steiner GE, Handisurya A et al. (2002) Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52: 43–58

    Article  PubMed  CAS  Google Scholar 

  7. Handisurya A, Steiner GE et al. (2001) Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate. Prostate 49: 251–262

    Article  PubMed  CAS  Google Scholar 

  8. Steiner GE, Stix U, Handisurya A et al. (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest 83: 1131–1146

    Article  PubMed  CAS  Google Scholar 

  9. Steiner GE, Newman ME, Paikl D et al. (2003) Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56: 171–182

    Article  PubMed  CAS  Google Scholar 

  10. Mitteregger D, Brozek W et al. (2007) Novel identification of interleukin (IL)-23 and IL-23 receptor (R) in the prostate: impact on growth regulation as revealed by inhibition of PC3 cell proliferation. AUA (in press)

  11. Konig JE, Senge T, Allhoff EP et al. (2004) Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate 58: 121–129

    Article  PubMed  Google Scholar 

  12. Kramer G, Steiner G, Edinnger D et al. (1995) High expression of a CD38-like molecule in normal prostatic epithelium and its differential loss in benign and malignant disease. J Urol 154: 1636–1641

    Article  PubMed  CAS  Google Scholar 

  13. Kramer G, Steiner GE et al. (2003) Loss of CD38 correlates with simultaneous up-regulation of human leukocyte antigen-DR in benign prostatic glands, but not in fetal or androgen-ablated glands, and is strongly related to gland atrophy. BJU Int 91: 409–416

    Article  PubMed  CAS  Google Scholar 

  14. Kramer G, Mitteregger D, et al. (2006) Benign prostatic hyperplasia specimens derived from patients after urinary retention show significantly more prostate glands with upregulation of HLA-DR and loss of CD38 than those derived from patients without urinary retention. Eur Urol 5(Suppl): 120

    Google Scholar 

  15. Nelson WG, De Marzo AM, Deweese TL, Isaacs WB (2004) The role of inflammation in the pathogenesis of prostate cancer. J Urol 172: 6–12

    Article  Google Scholar 

  16. Platz EA, De Marzo AM (2004) Epidemiology of inflammation and prostate cancer. J Urol 171: 36–40

    Article  Google Scholar 

  17. Palapattu GS, Sutcliffe S, Bastian PJ et al. (2005) Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 26: 1170–1181

    Article  PubMed  CAS  Google Scholar 

  18. De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155: 1985–1992

    Google Scholar 

  19. Mitteregger D, Aberle S, et al. (2007) Screening for pathogenic microorganisms in advanced benign prostatic hyperplasia (BPH). AUA (in press)

Download references

Author information

Authors and Affiliations

  1. Klinik für Urologie, Medizinische Universität, Währinger Gürtel 18-20, A-1090, Wien, Österreich

    G. Kramer, D. Mitteregger, A. Maj-Hes, S. Sevchenco & W. Brozek

Authors
  1. G. Kramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Mitteregger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Maj-Hes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Sevchenco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. Brozek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Kramer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kramer, G., Mitteregger, D., Maj-Hes, A. et al. Chronische Inflammation als Promotor- und Behandlungstarget bei benigner Prostatahyperplasie (BPH) und beim Prostatakarzinom. Urologe 46, 1095–1096 (2007). https://doi.org/10.1007/s00120-007-1444-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1444-0

Search

Navigation